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Comparison of two fluid-management strategies in acute lung injury
The National Heart, Lung, and Blood Institute Acute Respiratory Distress
Syndrome (ARDS) Clinical Trials Network; Wiedemann HP, Wheeler AP,
Bernard GR, et al. N Engl J Med 2006;354:2564-75
Conclusion: A conservative strategy of fluid management in patients
with acute lung injury shortens duration of mechanical ventilation without
increasing nonpulmonary organ failure.
Summary:There is debate about optimal fluidmanagement of patients
with acute lung injury. Limiting fluids or inducing diuresis may improve
lung function but at the expense of impaired perfusion of other organs. In
this randomized study, a conservative or liberal strategy of fluidmanagement
in patients with acute lung injuries was used. The protocol was applied for 7
days in 1000 patients with acute lung injury. The primary end point was
death at 60 days. Ventilator-free days and organ-failure-free days and mea-
sures of lung physiology were secondary end points. There was no difference
between the two groups in the primary end point at 60 days. In the
conservative strategy group, 25.5% of the patients died, and 28.4% of the
patients died in the liberal strategy group (P .30; 95% confidence interval
for a difference, 2.6% to 8.4%). The cumulative fluid balance in the first 7
days in the conservative strategy group was 136  491 mL. The cumula-
tive fluid balance in the first 7 days in the liberal strategy group was 6992
 502 mL (P  .001). The conservative strategy group had an improved
oxygenation index, lung injury score, and an increased number of ventilator-
free days (14.6 0.5 vs 12.1 0.5, P .001) vs the liberal strategy group.
The conservative strategy group also had more days not spent in the
intensive care unit (13.4  0.4 vs 11.2  0.4, P  .001) during the first 28
days. There was no difference between the conservative and liberal strategy
groups with respect to prevalence of shock during the course of the study or
the use of dialysis during the first 60 days (10% vs 14%, P  .06).
Comment: A conservative fluid management strategy did not decrease
death at 60 days vs a liberal fluid management strategy in patients with acute
respiratory distress syndrome. However, intensive care unit days were re-
duced and lung function was improved with the conservative fluid manage-
ment posture. The results are consistent with other recent reports suggesting
improved overall patient outcome with conservative fluid management in
acute respiratory distress syndrome. The days of essentially drowning pa-
tients with acute lung injury to preserve distal organ perfusion should be
over.
Chlamydia pneumoniae in foci of “early” calcification of the tunica
media in atherosclerotic arteries; an incidental presence?
Vobryshev YV, Lord RSA, Tran D. Am J Physio Heart Circ Physio 2006;
290:H1510-H1519
Conclusion: Chlamydia pneumoniae infection of medial smooth mus-
cle cells may be crucial to calcification of the tunica media in atherosclerotic
arteries.
Summary: The role of C pneumoniae infection in the pathogenesis of
atherosclerosis continues to be debated. This study investigated a possible
association between C pneumoniae infection and medial calcification. The
authors obtained carotid endarterectomy specimens from 60 patients. The
plaques were examined by polymerase chain reaction (PCR) and immuno-
histochemistry to identify presence of C pneumoniae. In this study, speci-
mens that were double-positive (positive by both PCR and immunohisto-
chemistry) were considered positive for the presence of C pneumoniae.
Double-negative and single-positive results were analyzed separately. There
were 17 specimens that were double-positive for C Pneumoniae. Twenty-
two specimens were negative with respect to both PCR and immunohisto-
chemistry, and 21 specimens showed single-positive results, being positive
with either PCR or immunohistochemistry for C pneumonia, but not with
both. Medial calcification was present in 58.8% (10 of 17) specimens
double-positive for C pneumoniae. There was no medial calcification ob-
served in any of the 22 specimens double-negative for C pneumoniae. In
areas of medial calcification, electronmicroscopy indicated the presence ofC
pneumoniae in smooth muscle cells. These smooth muscle cells showed
damage to the cytoplasm and basement membrane associated with elemen-
tary reticulate and aberrant bodies of C pneumoniae. Immunohistocyto-
chemistry techniques confirmed the presence of C pneumoniae in smooth
muscle cells.
Comment: There are two distinct forms of vascular calcification:
intimal calcification, which occurs in the context of atherosclerosis, and
medial calcification, which can occur without atherosclerosis. A variety of
different mechanisms can contribute to vascular calcification. The present
study suggests that the medial form of vascular calcification may be initiated
by the infection of medial smooth muscle cells byC pneumoniae.WhetherC
pneumoniae is required for eventual narrowing of the arterial lumen or
degeneration of the arterial wall is still unknown.
Post high-intensity focused ultrasound enhances thrombolysis in an in
vitro model
Frenkel V, Oberoi J, Stone MJ, et al.Radiology 2006; 239:86-93
Conclusion: Thrombolysis with tissue plasminogen activator (tPA)
can be enhanced using high-intensity pulsed focused ultrasound exposure.
Summary: Recent work has suggested ultrasound can serve as a
adjunct to thrombolytic drugs with enhancement of thrombolysis (N Engl
J Med 2004;351:2170-8). In the study summarized here, the authors
sought to evaluate, in an in vitro model, the potential utility of pulsed
high-intensity focused ultrasound to improve thrombolysis by tPA. Clots
were created by placing 1mL of human blood in isolated sections of Penrose
tubes. There were four experimental groups: a control group of untreated
clots, clots treated with tPA only, clots treated with only pulsed high-
intensity ultrasound, and finally, a group treated with both tPA and pulsed
high-intensity focused ultrasound. The efficacy of thrombolysis was mea-
sured by reduction in the mass of clot and by D-dimer levels. Experiments
also were performed to evaluate dose-response curves for two ultrasound
exposure parameters: number of pulses per raster point and total acoustic
power. Compared with control clots, clots treated with focused ultrasound
alone did not have increased levels of thrombolysis. Clots treated with
focused ultrasound plus tPA had a 50% increase in degree of thrombolysis
compared with clots treated with tPA only (P .001). D-dimer assay results
correlated with calculated degrees of thrombolysis. Clots treated with fo-
cused ultrasound plus tPA had a 53% higher release of D-dimer concentra-
tions compared with clots treated with tPA only (P  .001). Increasing the
number of pulses per raster point and total acoustic power resulted in
corresponding increases in thrombolysis rates.
Comment: The use of a combination of thrombolytic drugs and
focused ultrasound exposure has potential benefits, with possible quicker
resolution of thrombus and lower doses of thrombolytic agents. These are
changes that could result in decreased bleeding risk and decreased treatment
times. Presumably ultrasound enhances thrombolysis through mechanical
cavitation effects. A great deal of work will be required to evaluate the
effective doses of both the ultrasound and thrombolytic agents in various
clinical situations (eg, venous thrombi, arterial thrombi). Work such as this
presented here establishes the feasibility of dose-ranging studies for throm-
bolytic agents and ultrasound for dissolving clots. Such work is crucial to
future in vivo evaluation of a combination of ultrasound and thrombolytic
agents.
Correlates and long-term outcomes of angiographically proven stent
thrombosis with sirolimus-paclitaxel-eluting stents
Kuchulakanti PK, Chu WW, Torguson R. Circulation 2006;113:1108-13.
Conclusion: Renal failure, treatment of bifurcation lesions, in-stent
restenosis, and cessation of clopidogrel therapy correlate with thrombosis of
coronary artery stents.
Summary: Stent thrombosis is an infrequent, but serious complication
of drug-eluting coronary artery stents. The authors sought to establish risk
factors for coronary artery stent thrombosis associated with drug-eluting
stents. A total of 2974 consecutive patients were treated with drug-eluting
coronary artery stents, and 38 (1.27%) were identified by angiography to
have evidence of stent thrombosis. Thrombosis of the stent occurred acutely
in five patients,30 days in 25 patients, and30 days in eight patients. The
authors compared procedural angiographic and clinical factors of the pa-
tients with stent thrombosis vs 2936 consecutive patients who were treated
with drug-eluting stents for coronary disease and who did not experience
stent thrombosis during a period of 12 months of follow-up. Patients with
stent thrombosis compared with patients without stent thrombosis had a
higher frequency of diabetes, postprocedural renal failure, and chronic renal
failure. Patients with stent thrombosis had more bifurcation lesions and a
trend toward smaller diameter stents. The incidence of discontinuation of
clopidogrel therapy was higher in patients with stent thrombosis (36.8%) vs
patients without stent thrombosis (10.7%, P  .0001). At 6 months,
mortality was significantly higher in patients with stent thrombosis com-
pared with those without stent thrombosis (31% vs 3%; P  0.001).
Multivariant analysis suggested renal failure, bifurcation lesions, in-stent
restenosis, and cessation of clopidogrel therapy correlated with stent throm-
bosis (P  .05).
909
